Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia
Recruiting · NCT05199909 · Registry updated 2025-02-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Zanubrutinib in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia | Cytopenia, Hemic and Lymphatic Diseases, antiphospholipid syndrome, autoimmune disease, blood platelet disease, hematologic disorder, immune system disorder, thrombocytopenia | Recruiting | Phase 2 | 2025-02-24 | NCT05199909 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 285 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Chinese Academy of Medical Science and Blood Disease Hospital | Tianjin | China | 15 |
| Institute of Hematology & Blood Diseases Hospital | Tianjin | China | 24 |